212 related articles for article (PubMed ID: 20950330)
21. Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures.
Ben-Menachem E; Biton V; Jatuzis D; Abou-Khalil B; Doty P; Rudd GD
Epilepsia; 2007 Jul; 48(7):1308-17. PubMed ID: 17635557
[TBL] [Abstract][Full Text] [Related]
22. Intravenous lacosamide as replacement for oral lacosamide in patients with partial-onset seizures.
Biton V; Rosenfeld WE; Whitesides J; Fountain NB; Vaiciene N; Rudd GD
Epilepsia; 2008 Mar; 49(3):418-24. PubMed ID: 17888078
[TBL] [Abstract][Full Text] [Related]
23. Lacosamide as adjunctive therapy for partial-onset epileptic seizures: a review of the clinical and economic literature.
Simoens S
Curr Med Res Opin; 2011 Jul; 27(7):1329-38. PubMed ID: 21561394
[TBL] [Abstract][Full Text] [Related]
24. Lacosamide, a novel anti-convulsant drug, shows efficacy with a wide safety margin in rodent models for epilepsy.
Stöhr T; Kupferberg HJ; Stables JP; Choi D; Harris RH; Kohn H; Walton N; White HS
Epilepsy Res; 2007 May; 74(2-3):147-54. PubMed ID: 17433624
[TBL] [Abstract][Full Text] [Related]
25. Long-term safety and efficacy in patients with uncontrolled partial-onset seizures treated with adjunctive lacosamide: results from a Phase III open-label extension trial.
Husain A; Chung S; Faught E; Isojarvi J; McShea C; Doty P
Epilepsia; 2012 Mar; 53(3):521-8. PubMed ID: 22372628
[TBL] [Abstract][Full Text] [Related]
26. Lacosamide in patients with pharmacoresistant epilepsy.
Verrotti A; Loiacono G; Olivieri C; Zulli E; Zaccara G
Expert Opin Pharmacother; 2012 Oct; 13(14):2065-72. PubMed ID: 22873760
[TBL] [Abstract][Full Text] [Related]
27. The effects of lacosamide on cognition, quality-of-life measures, and quality of life in patients with refractory partial epilepsy.
Lancman ME; Fertig EJ; Trobliger RW; Perrine K; Myers L; Iyengar SS; Malik M
Epilepsy Behav; 2016 Aug; 61():27-33. PubMed ID: 27315132
[TBL] [Abstract][Full Text] [Related]
28. Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group.
Maschio M; Zarabla A; Maialetti A; Fabi A; Vidiri A; Villani V; Giannarelli D
Epilepsy Behav; 2017 Aug; 73():83-89. PubMed ID: 28623754
[TBL] [Abstract][Full Text] [Related]
29. Intravenous Lacosamide in Pediatric Status Epilepticus: An Open-Label Efficacy and Safety Study.
Poddar K; Sharma R; Ng YT
Pediatr Neurol; 2016 Aug; 61():83-6. PubMed ID: 27241232
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of lacosamide in children and adolescents with drug-resistant epilepsy and refractory status epilepticus: A systematic review.
Ortiz de la Rosa JS; Ladino LD; Rodríguez PJ; Rueda MC; Polanía JP; Castañeda AC
Seizure; 2018 Mar; 56():34-40. PubMed ID: 29428899
[TBL] [Abstract][Full Text] [Related]
31. [The experience treatment of adjunctive lacosamide for patients with drug-resistance partial epilepsy].
Kissin MY; Bondarenko II
Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(9):23-8. PubMed ID: 24107876
[TBL] [Abstract][Full Text] [Related]
32. New epilepsy treatment receives FDA approval.
Lavine G
Am J Health Syst Pharm; 2008 Dec; 65(24):2310. PubMed ID: 19052267
[No Abstract] [Full Text] [Related]
33. Efficacy and safety of lacosamide in infants and young children with refractory focal epilepsy.
Grosso S; Parisi P; Spalice A; Verrotti A; Balestri P
Eur J Paediatr Neurol; 2014 Jan; 18(1):55-9. PubMed ID: 24129195
[TBL] [Abstract][Full Text] [Related]
34. Successful treatment for refractory convulsive status epilepticus by non-parenteral lacosamide.
Tilz C; Resch R; Hofer T; Eggers C
Epilepsia; 2010 Feb; 51(2):316-7. PubMed ID: 19674050
[TBL] [Abstract][Full Text] [Related]
35. Lacosamide: in partial-onset seizures.
Cross SA; Curran MP
Drugs; 2009; 69(4):449-59. PubMed ID: 19323588
[TBL] [Abstract][Full Text] [Related]
36. Lacosamide for epilepsy.
Med Lett Drugs Ther; 2009 Jun; 51(1315):50-2. PubMed ID: 19556941
[No Abstract] [Full Text] [Related]
37. [Efficacy and safety of a new antiepileptic drug lacosamide in patients with focal epilepsy: data of double-blind placebo controlled trials].
Mil'chakova LE; Gekht AB
Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(3 Suppl 2):39-43. PubMed ID: 20873472
[No Abstract] [Full Text] [Related]
38. Intravenous lacosamide in clinical practice-Results from an independent registry.
Lang N; Lange M; Schmitt FC; Bös M; Weber Y; Evers S; Burghaus L; Kellinghaus C; Schubert-Bast S; Bösel J; Lammers T; Sabolek M; van Baalen A; Dziewas R; Kraft A; Ruf S; Stephani U
Seizure; 2016 Jul; 39():5-9. PubMed ID: 27161669
[TBL] [Abstract][Full Text] [Related]
39. Lacosamide as adjunctive therapy in refractory epilepsy in adults: a systematic review.
Paquette V; Culley C; Greanya ED; Ensom MH
Seizure; 2015 Feb; 25():1-17. PubMed ID: 25645629
[TBL] [Abstract][Full Text] [Related]
40. Clinical pharmacokinetic and pharmacodynamic profile of lacosamide.
Cawello W
Clin Pharmacokinet; 2015 Sep; 54(9):901-14. PubMed ID: 25957198
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
